Check-Cap (NASDAQ:MBAI) Stock Price Down 1.5% – What’s Next?

Check-Cap Ltd (NASDAQ:MBAI)’s share price fell 1.5% on Wednesday . The company traded as low as $1.00 and last traded at $1.01. 7,137 shares changed hands during mid-day trading, a decline of 90% from the average session volume of 69,051 shares. The stock had previously closed at $1.0250.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Check-Cap in a report on Friday, April 24th. One analyst has rated the stock with a Sell rating, According to MarketBeat, the stock has an average rating of “Sell”.

Check-Cap Trading Down 1.5%

The business’s fifty day moving average price is $1.39. The company has a market cap of $7.36 million, a price-to-earnings ratio of -0.50 and a beta of 0.65.

About Check-Cap

Check-Cap Ltd. (NASDAQ: MBAI) is an Israel-based medical technology company focused on non-invasive screening solutions for colorectal cancer. The company develops an ingestible imaging capsule and associated detection system intended to provide a patient-friendly alternative to traditional colonoscopy and CT colonography for colorectal screening and polyp detection.

Check-Cap’s technology centers on a swallowable capsule that acquires images of the colon as it traverses the gastrointestinal tract; external detectors capture the transmitted signals and software reconstructs images for clinical review.